Chemotherapy responsive collagenous colitis in a patient with Hodgkin's disease: a possible paraneoplastic phenomenon.
S D
SD
van der Werf
G P
GP
van Berge Henegouwen
F B
FB
Bronkhorst
J M
JM
Werre
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001485:Basement Membrane / Q000473:pathology; D003092:Colitis / Q000150:complications*; D003095:Collagen Diseases / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D003967:Diarrhea / Q000188:drug therapy; D005260:Female; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008466:Mechlorethamine / Q000008:administration & dosage; D010257:Paraneoplastic Syndromes / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011350:Proctocolitis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone